Exploring the Influencing Factors of COVID-19 Vaccine Acceptance Among Bangladeshi People

Authors

  • Md. Mahbube Azizul Hakim
  • Md. Farhaduzzaman Bhuiyan
  • Nahid Salma

Keywords:

COVID-19, coronavirus, vaccine, vaccination campaign, astraZeneca, Sinopharm

Abstract

This study attempts to identify the factors that led individuals to take the COVID-19 vaccine, as well as their concerns regarding the vaccine and vaccination campaign. Results indicated that respondents had a favorable impression of the government’s initiative. Where the majority of participants were male, 258 people who got at least one dose of either of the authorized COVID-19 vaccines were included in this study. The Cochran formula was used to determine the sample size. The Sinopharm vaccination was provided to the majority of respondents (51.94%), while 33% received the secondhighest dose of AstraZeneca. Family members have taken the COVID-19 vaccine was the most influencing factors (39.5%) behind taking vaccine. Among other factors: opportunity to receive it for free (33.3%), social responsibility (22.9%), and people found very much optimistic about the vaccination program as well (13.6%). They had no doubts about the vaccine’s availability or authenticity (13.2%). Any immediate reaction after taking the vaccine is also not reported by any of the respondents. The findings from the analysis would be a great help for the government, health care departments and policy makers to make better decisions regarding COVID-19 vaccine.

References

Lone SA, Ahmad A. COVID-19 pandemic–an African perspective. Emerg Microbes Infect. 2020;9(1):1300-8. doi: 10.1080/22221751.2020.1775132, PMID 32458760.

Mahmud S, Mohsin M, Khan IA, Mian AU, Zaman MA. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLOS ONE. 2021; 16 (9): e0257096. doi: 10.1371/journal.pone.0257096, PMID 34499673.

World Health Organization. (2022). Weekly epidemiological update on COVID-19-15 June 2022. [Online] Available December 10, 2022, from at https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---15-june-2022 [Accessed on February 2023]

Islam MT, Talukder AK, Siddiqui MN, Islam T. Tackling the COVID-19 pandemic: the Bangladesh perspective. J Public Health Res. 2020; 9 (4): 1794. doi: 10.4081/jphr.2020.1794, PMID 33117758.

Kumar V, Alshazly H, Idris SA, Bourouis S. Evaluating the impact of COVID-19 on society, environment, economy, and education. Sustainability. 2021; 13 (24): 13642. doi: 10.3390/SU132413642.

GWD. (n.d.). COVID-19 vaccine update from Bangladesh. [Online] Available at https://workerdiaries.org/covid-19-vaccine-update-from-bangladesh/ [Accessed on February 2023]

Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S et al. COVID-19 vaccine hesitancy among the adult population in Bangladesh: a nationwide cross-sectional survey. PLOS ONE. 2021; 16 (12): e0260821. doi: 10.1371/journal.pone.0260821, PMID 34882726.

Mahmud-Al-Rafat A, Hewins B, Mannan A, Kelvin DJ, Billah MM. COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh. Lancet Infect Dis. 2022; 22 (3): 310–312. doi: 10.1016/S1473-3099(22)00028-7, PMID 35101243.

Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021; 10 (7): 1428. doi: 10.3390/jcm10071428, PMID 33916020.

Ali M, Hossain A. What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey. BMJ Open. 2021; 11 (8): e050303. doi: 10.1136/bmjopen-2021-050303, PMID 34429316.

Ahmad Chaudhary F, Ahmad B, Danial Khalid M, Fazal A, Mohsin Javaid M, Qasim Butt D et al. Hum Vaccin Immunother. 2021; 17 (10): 3365–3370. doi: 10.1080/21645515.2021.1944743.

Downloads

Published

2023-02-04

Issue

Vol. 12 No. 3 (2022)

Section

Research Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.